✦ LIBER ✦

German Experience With Bendamustine Treating Relapsed/Refractory Indolent B-Cell and Mantle Cell Lymphomas

✍ Scribed by Mathias J. Rummel

Book ID: 117822029
Publisher: Elsevier Science
Year: 2007
Tongue: English
Weight: 409 KB
Volume: 44
Category: Article
ISSN: 1532-8686
DOI: 10.1053/j.seminhematol.2007.06.003

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Multicenter phase II study of bendamusti

Multicenter phase II study of bendamustine for relapsed or refractory indolent B-cell non-Hodgkin lymphoma and mantle cell lymphoma

✍ Ken Ohmachi; Kiyoshi Ando; Michinori Ogura; Toshiki Uchida; Kuniaki Itoh; Nobuko 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 206 KB

Phase I and pharmacokinetic study of ben

Phase I and pharmacokinetic study of bendamustine hydrochloride in relapsed or refractory indolent B-cell non-Hodgkin lymphoma and mantle cell lymphoma

✍ Michinori Ogura; Toshiki Uchida; Masafumi Taniwaki; Kiyoshi Ando; Takashi Watana 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 174 KB

Phase II Multicenter Study of Bendamusti

Phase II Multicenter Study of Bendamustine Plus Rituximab in Patients With Relapsed Indolent B-Cell and Mantle Cell Non-Hodgkin's Lymphoma

✍ Robinson, K. S.; Williams, M. E.; van der Jagt, R. H.; Cohen, P.; Herst, J. A.; 📂 Article 📅 2008 🏛 American Society of Clinical Oncology 🌐 English ⚖ 119 KB

Bendamustine combined with rituximab for

Bendamustine combined with rituximab for patients with relapsed or refractory diffuse large B cell lymphoma

✍ Vacirca, Jeffrey L.; Acs, Peter. I.; Tabbara, Imad A.; Rosen, Peter. J.; Lee, Pe 📂 Article 📅 2013 🏛 Springer 🌐 English ⚖ 339 KB

Bendamustine as salvage treatment for pa

Bendamustine as salvage treatment for patients with relapsed or refractory mantle cell lymphoma patients: a retrospective study of the Spanish experience

✍ A. García-noblejas; C. Martínez Chamorro; B. Navarro Matilla; C. Da Silva Rodrig 📂 Article 📅 2014 🏛 Springer 🌐 English ⚖ 344 KB

Retreatment with bendamustine-containing

Retreatment with bendamustine-containing regimens in patients with relapsed/refractory chronic lymphocytic leukemia and indolent B-cell lymphomas achieves high response rates and some long lasting remissions

✍ Weide, Rudolf; Feiten, Stefan; Friesenhahn, Vera; Heymanns, Jochen; Kleboth, Kri 📂 Article 📅 2012 🏛 Informa plc 🌐 English ⚖ 260 KB